Fact-checked by Grok 2 weeks ago

Chloral

Chloral, also known as trichloroacetaldehyde, is an with the molecular formula C₂HCl₃O and a molecular weight of 147.39 g/mol. It is a colorless, oily, hygroscopic liquid with a pungent , a of 97.8°C, a of -57.5°C, and a density of 1.51 g/cm³ at 20°C. Soluble in , , , and , chloral readily reacts with to form (C₂H₃Cl₃O₂), a that exists in equilibrium with the . This reactivity also leads to polymerization under exposure to light or , forming metachloral. First synthesized in 1832 by German chemist via chlorination of , chloral marked an early achievement in . Commercial production began in the 1940s, primarily through chlorination of or using catalysts like , with global output peaking at around 40,000 tonnes annually in the United States by 1963. Its industrial significance grew during due to demand for insecticides, but production declined sharply after the 1972 U.S. ban on , reducing U.S. output to negligible levels by the 1990s. The primary use of chloral has been as an intermediate in the manufacture of pesticides, including dichlorodiphenyltrichloroethane (), methoxychlor, naled, trichlorfon, and , accounting for about 40% of U.S. consumption in 1975. It also serves in producing (a and protein precipitant), polyurethane foams, and pharmaceuticals such as (a historical ), chloral betaine, α-chloralose (a bird repellent), and triclofos sodium. Additionally, chloral induces swelling in granules for industrial applications and occurs as a disinfection in chlorinated , with concentrations typically ranging from 0.01 to 28 µg/L in U.S. supplies. Chloral is toxic by and , causing to the skin, eyes, and , with an oral LD50 of 480 mg/kg in rats (for the form). It has low bioconcentration potential and is classified by the Agency for Research on Cancer (IARC) as Group 2A (probably carcinogenic to humans) as of 2014. Occupational exposure limits are limited, with setting a short-term workplace threshold of 5 mg/m³ and an ambient air standard of 0.01 mg/m³; the U.S. EPA has proposed a limit of 0.04 mg/L. Today, chloral is produced by a small number of companies in countries like and , reflecting its reduced but ongoing role in specialized .

Properties

Molecular structure

Chloral has the molecular formula C₂HCl₃O and is systematically named 2,2,2-trichloroacetaldehyde or trichloroethanal. The molecular structure consists of an functional group (-CHO) in which the carbonyl carbon is double-bonded to an oxygen atom and single-bonded to a and to a trichloromethyl group (CCl₃-), represented as Cl₃C–CHO. This arrangement positions the three atoms on the α-carbon adjacent to the carbonyl, creating a linear chain with two carbons total. The C–Cl bonds exhibit significant due to the difference between carbon and ( of 2.55 and 3.16, respectively), rendering the trichloromethyl group electron-withdrawing and enhancing the electrophilic character of the carbonyl carbon. The overall molecule is polar, with a of 17.1 Ų, primarily from the polar and C–Cl bonds. Chloral possesses no stable isomers, existing solely in this constitutional form as a chlorinated derivative of (CH₃CHO), where the three methyl hydrogens are replaced by chlorines.

Physical properties

Chloral appears as a colorless oily liquid at . It has a of −57.5 °C and a of 97.8 °C at 760 mmHg. The is 1.51 g/cm³ at 20 °C. Chloral is miscible with organic solvents such as , , and . It reacts with water to form , which is highly soluble; the form has limited intrinsic , attributable to the polar contrasted with the hydrophobic trichloromethyl moiety. Chloral exhibits a pungent, irritating . It is volatile, with a of 35 mmHg at 20 °C, and remains stable under ambient conditions when maintained in form. In , the shows absorption around 1740 cm⁻¹. The proton in ¹H NMR spectroscopy appears at approximately 9.4 ppm.

History

Discovery

Chloral was first synthesized in 1832 by the German chemist at the through the chlorination of anhydrous with dry gas. This reaction produced chloral as an intermediate, which Liebig isolated during experiments aimed at understanding the of alcohols. Liebig detailed in a publication in the inaugural issue of Annalen der Pharmacie, noting that the chlorination proceeded at varying temperatures to yield the compound. Liebig characterized chloral as a colorless, oily, hygroscopic liquid with a pungent, irritating , which was volatile and tended to form a upon exposure to moisture. Initially, he identified it as a distinct substance related to chlorinated alcohols but distinct from , though early samples were sometimes confounded with the latter due to overlapping reaction products. This discovery occurred amid the burgeoning field of in the early , where chemists like Liebig were pioneering systematic studies of halogenated organic compounds to elucidate reaction mechanisms and synthetic pathways. Liebig's work on chloral exemplified the era's emphasis on empirical experimentation and structural elucidation, contributing to foundational advances in synthetic .

Development and early recognition

Following the initial synthesis of chloral in 1832 by through the chlorination of , mid-19th-century chemists advanced its purification and characterization. In 1847, Adolph Staedeler reported detailed studies on chloral, including methods for obtaining purer forms by and reaction analysis, which helped distinguish it from impurities in early preparations. These efforts built on Liebig's work and facilitated a clearer understanding of chloral as trichloroacetaldehyde, separate from related chlorinated compounds. A pivotal advancement came in 1869 when German pharmacologist Oscar Liebreich explored the hydrate form of chloral () for potential medical applications. Liebreich's experiments on animals demonstrated that subcutaneous or induced deep sleep without the effects of , attributing the hypnotic action initially to decomposition into . His , Das Chloralhydrat: Ein neues und Anaestheticum, published that year, detailed these findings and advocated its use as a for anxiety and . This work marked the shift from chloral as a chemical curiosity to a recognized pharmaceutical agent, with early human trials confirming its efficacy in inducing sleep. By the early 1870s, chloral hydrate gained widespread medical adoption in Germany as the first synthetic hypnotic, appearing in pharmacopoeias and clinical practice for sedation. Pharmacological studies published around 1870 further documented its rapid onset and short duration, solidifying its role in treating sleep disorders and nervous conditions. However, early scientific debates arose over its mechanism, stemming from confusion with chloroform due to structural similarities and shared chlorine content; Liebreich's hypothesis of metabolic conversion was later challenged in the 1870s. Notably, in 1875, physiologist Claude Bernard demonstrated through experiments that no chloroform is produced in the body upon administration of chloral hydrate. The exact mechanism of action, involving reduction to the active metabolite trichloroethanol independent of chloroform formation, was elucidated later in 1948.

Production

Industrial methods

The primary industrial process for chloral production involves the chlorination of or under acidic conditions to achieve stepwise substitution of atoms with . This method ensures commercial viability by controlling side reactions through a gradual increase, typically starting at 0 °C and ramping up to 90 °C, which optimizes yield and minimizes over-chlorination. The proceeds in solution, where may serve as an additional catalyst to enhance rates. A simplified overview of the process using ethanol as feedstock is:
\ce{CH3CH2OH + 4Cl2 -> Cl3CCHO + 5HCl}
This stepwise chlorination first forms intermediates like chloral alcoholate before yielding trichloroacetaldehyde (chloral). Hydrochloric acid acts as both solvent and catalyst, facilitating the substitution while the temperature ramp—often in stages from 0–30 °C, 50–60 °C, to 80–90 °C—prevents excessive heat that could lead to decomposition or unwanted byproducts. Following chlorination, the mixture undergoes distillation to isolate chloral, separating it from byproducts such as chloroform formed via minor haloform reaction pathways.
This process was developed in the late to meet growing pharmaceutical demand for , the hydrated form of chloral used as a . Industrial-scale operations, often batch or semicontinuous, emerged around the as chloral hydrate gained medical prominence, with production scaled via large reactors handling chlorine gas feeds efficiently. Today, global output remains limited and closely tied to chloral hydrate needs in pharmaceuticals and niche applications, with major producers in regions like , , and maintaining capacities on the order of thousands of tonnes annually. Environmental considerations in chloral production center on the handling of gas, a hazardous reactant sourced from the chlor-alkali industry, and the generation of as a , which requires neutralization or recycling to manage waste streams. Modern facilities incorporate and recovery to mitigate emissions, though the process's reliance on contributes to overall chlorine consumption in the chemical sector.

Laboratory synthesis

In laboratory settings, chloral (trichloroacetaldehyde) is commonly synthesized on a small scale by the chlorination of paraldehyde, the cyclic trimer of acetaldehyde, using chlorine gas in the presence of a sulfur catalyst. This method allows for controlled reaction conditions and is adaptable for educational or research purposes, contrasting with large-scale industrial processes. The procedure begins by drying paraldehyde over calcium chloride to ensure anhydrous conditions, then introducing a small amount of elemental sulfur (typically 0.1-0.5% by weight) as a catalyst to facilitate the substitution of hydrogen atoms with chlorine. Chlorine gas is introduced slowly into the mixture at 30-50°C to form hexachloroparaldehyde as an intermediate, avoiding over-chlorination by monitoring the reaction progress through weight gain or gas absorption. The intermediate is then depolymerized under aqueous conditions at 40-90°C with additional chlorine to yield chloral, with typical overall yields of 70-80% based on paraldehyde conversion. Purification is achieved by under reduced pressure (boiling point ~97°C at 760 mmHg, lower under to prevent ), collecting the between 92-98°C to obtain chloral as a colorless, mobile . conditions throughout are critical to prevent unwanted hydration to , which can be reversed by with concentrated if needed. This sulfur-catalyzed approach provides high purity (>95%) suitable for subsequent reactions in . An alternative laboratory route involves the oxidation of trichloroethanol to chloral. Trichloroethanol is first prepared by reduction of trichloroacetyl chloride with in at -10 to 10°C, yielding 83-85% after . The alcohol is then oxidized using (1.2-2.5 molar excess) and a catalyst like (1-5 mol%) at -10 to 0°C for 0.5-2 hours, followed by to isolate chloral with 74.5-75% yield and 98% purity. This method avoids direct handling of gas, making it safer for small-scale work. Another option is the reaction of with under high-temperature conditions (200-500°C) and elevated (20-200 ), often with a metal like to promote the formation of chloral. However, this requires specialized equipment and is less common in standard laboratories due to the extreme conditions. Yields are not well-quantified for lab scales but can reach moderate levels with recirculation of unreacted materials. All syntheses must be conducted in a well-ventilated owing to the release of toxic gas and the irritant nature of chloral vapors, with protective equipment essential to minimize exposure risks.

Chemical reactions

Formation of

Chloral hydrate forms through the reversible addition of water to chloral (trichloroacetaldehyde), represented by the reaction: \mathrm{Cl_3CCHO + H_2O \rightleftharpoons Cl_3CCH(OH)_2} This process establishes an that strongly favors the hydrated gem-diol form in aqueous . The hydration K_\mathrm{hyd} for this reaction is approximately $2.8 \times 10^4 at , corresponding to over 99.99% of the species existing as in . This pronounced preference arises from the mechanism of , in which acts as a attacking the electrophilic carbonyl carbon of chloral; the three electron-withdrawing chlorine atoms enhance the carbonyl's reactivity by increasing its partial positive charge and stabilizing the tetrahedral and resulting through inductive effects. To isolate anhydrous chloral, chloral hydrate undergoes dehydration via , which shifts the toward the by removing under reduced . The recognition of this hydration reaction in the enabled the preparation and clinical introduction of as the first synthetic sedative-hypnotic agent by Otto Liebreich in 1869.

Other key reactions

Chloral engages in aldol-type reactions with active methylene compounds, leading to trichloromethyl-substituted β-hydroxy carbonyl products. For instance, condenses with acetone in the presence of catalyst in at 70°C, yielding 1,1,1-trichloro-2-hydroxy-4-pentanone as the primary product via of the acetone to the chloral carbonyl, without subsequent due to the stability of the . The can be reduced to 2,2,2-trichloroethanol using appropriate reducing agents. One method involves heating chloral with ethanol and aluminum ethoxide under at 120–135°C for approximately 24 hours, followed by acid and , affording the alcohol in 84% yield. Oxidation of chloral with strong oxidants converts it to . Traditional routes employ , , or under acidic conditions ( 1–4) at 50–60°C, with yields up to 67% reported using and . A notable application is the synthesis of the , where chloral reacts with two equivalents of in concentrated at controlled temperatures (typically 20–40°C) to form 1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane via on the activated rings. Chloral exhibits limited polymerization tendencies on its own, forming the cyclic trimer metachloral under acidic conditions or light exposure. It can also react with to produce resins, though such processes are not widely utilized.

Applications

Pharmaceutical applications

, the hydrated form of chloral, serves as the primary pharmaceutical derivative employed in medicine as a -hypnotic agent. It was introduced into in 1869 by Oskar Liebreich and rapidly became the first synthetic , widely prescribed from the late 19th century through the mid-20th century for treating and inducing . This historical prominence stemmed from its effectiveness in promoting sleep and reducing anxiety, marking a significant advancement over earlier natural sedatives like or bromides. The therapeutic effects of chloral hydrate arise from its rapid metabolism in the liver to trichloroethanol, the responsible for . Trichloroethanol potentiates the activity of gamma-aminobutyric acid () at GABA-A receptors, enhancing inhibitory in the brain and producing and outcomes similar to barbiturates. This mechanism facilitates its use in short-term management of sleep disturbances or as a premedication for induction, typically administered orally in doses ranging from 500 mg to 2,000 mg for adults, taken 15-30 minutes before bedtime. Common formulations include 500 mg capsules and oral solutions such as 500 mg/5 mL syrup, which allow for precise dosing and ease of administration, particularly in or veterinary settings. In , it has been used for procedural , often at 25-50 mg/kg per dose, while veterinary applications include calming agitated animals like dogs via . Other derivatives include chloral betaine, a sedative-hypnotic introduced in 1963 for short-term treatment of severe , and triclofos sodium, used primarily for in children undergoing procedures due to its better palatability compared to . By the late , chloral hydrate's use declined due to the emergence of safer alternatives like benzodiazepines and non-barbiturate hypnotics, which offer better tolerability and lower risk profiles. It is no longer approved by the U.S. FDA or for routine medical indications and has been restricted in pediatric use in regions like the to short-term applications only, with veterinary availability limited to compounded preparations in some countries.

Industrial and other uses

Chloral has historically been a principal intermediate in the production of the insecticide , synthesized by condensing chloral with in the presence of , with widespread agricultural and commercial application from the to the . This use drove significant production volumes, as DDT output reached peaks of over 80,000 metric tons annually in the United States during the mid-20th century, reflecting chloral's scale in manufacturing before regulatory bans. Beyond , chloral serves as a precursor for other insecticides including methoxychlor, naled, trichlorfon, and , as well as in the synthesis of herbicides through . It also functions as a in broader for dyes and related compounds. In , chloral acts as a for fats, waxes, and resins, and contributes to the production of rigid foams. Today, chloral's uses are niche, primarily in developing regions like , , and for producing generics and as an analytical reagent, such as a clearing agent for . Global annual production is estimated at around 10,000 tons in the 2020s, concentrated in amid declining demand from pesticide restrictions.

Toxicology and safety

Toxicity mechanisms

Chloral, or trichloroacetaldehyde, undergoes rapid hydration to form , which is the primary species responsible for its pharmacological and toxic effects. This metabolite is then reduced primarily by in hepatic and extrahepatic tissues to trichloroethanol, the active metabolite mediating sedative-hypnotic actions, with further oxidation to occurring via . These metabolic transformations occur swiftly, with peak plasma levels of trichloroethanol appearing within 15-30 minutes after in . The primary acute toxic effects of chloral stem from (CNS) depression, which occurs even at therapeutic doses due to the GABA_A receptor-enhancing activity of trichloroethanol. In overdose scenarios, this progresses to profound respiratory , , and , reflecting enhanced inhibitory and suppression of respiratory centers. The (LD50) for oral administration of in rats is approximately 480 mg/kg body weight, underscoring its narrow . Chloral acts as a potent mucosal irritant owing to the high reactivity of its group, which can form adducts with nucleophilic sites on proteins and in epithelial tissues. Upon , in the acidic gastric environment exacerbates this, leading to corrosion of the , hemorrhagic , and potential ulceration through direct chemical injury and inflammatory cascades. Chloral and are each considered probably carcinogenic to humans (), based on sufficient evidence of liver tumors in experimental animals from the metabolite and supporting mechanistic considerations. Studies in mice exposed to via have shown dose-related increases in hepatocellular adenomas and carcinomas, attributed to peroxisome proliferation and in hepatocytes. Chronic to chloral or its metabolites may promote fatty liver through disruption of in hepatocytes, as evidenced by increased liver weights and in long-term rodent studies.

Handling and exposure risks

Chloral, or trichloroacetaldehyde, poses significant risks through multiple pathways, primarily due to its irritant and toxic properties. Inhalation of its vapors can irritate the , leading to symptoms such as coughing, wheezing, and , with higher concentrations potentially causing sleepiness, , , or fainting. Dermal contact with chloral may result in severe skin irritation or burns, while eye can cause serious irritation. Ingestion leads to damage, including gastric irritation and symptoms like . No specific occupational exposure limits, such as an OSHA (PEL), have been established for chloral, though safe handling practices are recommended to minimize exposure below levels that produce adverse effects. Workers should use local exhaust ventilation to control airborne concentrations and monitor for symptoms of overexposure, including respiratory distress or effects. Proper storage and handling are essential to prevent unintended reactions and exposures. Chloral should be stored in tightly closed containers in a cool, well-ventilated area away from light, water (to avoid formation of ), ignition sources, oxidizing agents like perchlorates or peroxides, and strong acids such as hydrochloric or . (PPE), including chemical-resistant gloves, protective clothing, and respirators where vapor exposure is possible, is required during handling; workers must wash thoroughly after contact and be trained on procedures. In case of exposure, immediate is critical. For dermal or ocular , flush affected areas with large amounts of for at least 15 minutes and seek medical attention. incidents require moving the individual to , providing oxygen if breathing is difficult, and obtaining emergency medical care; CPR may be necessary if breathing stops. For , do not induce ; administer activated charcoal if advised by medical professionals, followed by supportive care to address gastrointestinal damage and potential metabolic effects. Spills should be managed by evacuating the area, eliminating ignition sources, absorbing with inert materials like or sand, and ventilating; fires involving chloral may release toxic gases such as , requiring dry chemical, CO2, or spray extinguishers. Environmentally, chloral hydrate—a form derived from chloral—persists in water as a disinfection from chlorination processes involving organic precursors like humic acids. Its low (log Kow of 0.99) indicates minimal potential in aquatic organisms.

References

  1. [1]
    Chloral | C2HCl3O | CID 6407 - PubChem - NIH
    This compound is sensitive to exposure to moisture and light. Soluble in water. This compound reacts with water to form chloral hydrate. CAMEO Chemicals ...
  2. [2]
    CHLORAL AND CHLORAL HYDRATE - NCBI - NIH
    The principal historical use of chloral has been in the production of the insecticide dichlorodiphenyltrichloroethane (DDT) and, to a lesser extent, other ...
  3. [3]
    Chloral
    Summary of each segment:
  4. [4]
    Chloral - CAS Common Chemistry
    Compound Properties. Boiling Point (1). 97.8 °C @ Press: 760 Torr. Melting Point (1). -57.5 °C. Density (1). 1.5121 g/cm³ @ Temp: 20 °C. Source(s).
  5. [5]
    Trichloroacetaldehyde: Uses, Interactions, Mechanism of Action
    Jun 13, 2005 · Structure for Trichloroacetaldehyde (DB02650) · 2,2,2-trichloroacetaldehyde · Anhydrous chloral · Chloral · Tri-chloro-acetaldehyde ...
  6. [6]
  7. [7]
    Justus von Liebig: Great Teacher and Pioneer in Organic Chemistry ...
    May 1, 2023 · He obtained chloroform via an alkaline cleavage of chloral, or trichloroacetaldehyde. He also published on a wide variety of other topics in ...
  8. [8]
    [PDF] on the reaction between chloral and amines - Arkivoc
    In the first issue (1832) of Annalen der Pharmacie (later to become Justus Liebig's Annalen der. Chemie) Justus Liebig published an abstract of his studies ...
  9. [9]
    Chloral and Chloral Hydrate - NCBI - NIH
    Name: 2,2,2-Trichloro-l,1-ethanediol. IUPAC Systematic Name: Chloral hydrate. Synonyms: Chloral monohydrate; trichloroacetaldehyde hydrate; ...
  10. [10]
    Justus von Liebig - MDPI
    May 6, 2023 · This is a short overview of the life and achievements of Justus von Liebig. Clearly, this can only be an incomplete and somewhat personal view of the author.
  11. [11]
    Justus von Liebig (1803–1873): a chemist's contributions to ...
    von Liebig informed the readers of his journal, Annalen der Pharmacie, about the discovery in a short article, “Surgical operations under the influence of ...
  12. [12]
  13. [13]
    [PDF] Early drug discovery and the rise of pharmaceutical chemistry
    Apr 28, 2011 · Portrait of Oscar Liebreich alongside the first page of his 1869 monograph on chloral hydrate and its use as a hypnotic. barbituric acid ...
  14. [14]
    Liebreich O (1869) - The James Lind Library
    “Having shown the effect [of chloral] in animals, I believed myself justified in proceeding to experiments in humans. Thanks to the amiability of Professors ...Missing: mid- 19th century Oscar
  15. [15]
    Early drug discovery and the rise of pharmaceutical chemistry - Jones
    Jun 23, 2011 · In 1832, Liebig also prepared chloral hydrate and showed that in alkaline solution it was converted into chloroform and formic acid. This ...Missing: initial | Show results with:initial
  16. [16]
    The history of barbiturates a century after their clinical introduction
    The first drug that could truly be called hypnotic is chloral hydrate. Synthesized in 1832 by Justus von Liebig, a chemist from Giessen, it was not analyzed ...
  17. [17]
    Sedatives in the second part of the 19th century - INHN
    Feb 15, 2018 · Chloral, or trichloroacetaldehyde, was first prepared in 1832 by Justus von Liebig, a professor of chemistry in Giessen (Germany). It was about ...
  18. [18]
    Chloral and chloral hydrate - Some Drinking-water Disinfectants and ...
    Chloral is produced commercially by the chlorination of acetaldehyde or ethanol in hydrochloric acid, during which antimony trichloride may be used as a ...
  19. [19]
    US2478152A - Preparation of chloral and chloral hydrate
    This invention relates to the manufacture of chlorinated products by the chlorination of ethanol (ethyl alcohol). More particularly, it is directed to the ...
  20. [20]
    Paraldehyde - an overview | ScienceDirect Topics
    Direct action of bromine (or chlorine) on aldehydes or ketones in the presence of acidic or basic catalysts leads to replacement of one or more of the α- ...
  21. [21]
    US2768173A - Preparation of chloral - Google Patents
    An important concept of this invention resides in the anhydrous chlorination of paraldehyde with chloral or preferably in the presence of the reaction product ...Missing: laboratory | Show results with:laboratory
  22. [22]
    Preparation method of chloral hydrate - Google Patents
    justus Liebig chlorinates anhydrous ethanol for the first time in 1832, and then the chloral (the chloral hydrate-chloral hydrate is generated by hydration ...<|control11|><|separator|>
  23. [23]
  24. [24]
    Chloral - the NIST WebBook
    Individual Reactions. Chloral + Water = Chloral Hydrate. By formula: C2HCl3O + H2O = C2H3Cl3O2. Quantity, Value, Units, Method, Reference, Comment. ΔrH°, -51.76 ...Missing: mechanism | Show results with:mechanism
  25. [25]
  26. [26]
    Organic Reactions
    Protonation of the oxygen atom increases the polarity of the carbonyl bond. This increases the rate at which a water molecule can act as a nucleophile toward ...Missing: trichloroacetaldehyde | Show results with:trichloroacetaldehyde
  27. [27]
    US2746912A - Production of chloral of low water content - Google ...
    Vacuum distillation of chloral-water mixtures has ... Mixtures of chloral and water corresponding to chloral hydrate contain one mol of water ... dehydration ...
  28. [28]
    [Chloral hydrate: a hypnotic best forgotten?] - PubMed
    Since 1869 it has been in use for hypnotic or sedative purposes. Chloral hydrate was used a lot from the end of the 19th century to the middle of the 20th ...Missing: trichloroacetaldehyde | Show results with:trichloroacetaldehyde
  29. [29]
    trichloroethyl alcohol - Organic Syntheses Procedure
    The action of a small proportion of aluminum ethoxide on pure chloral or chloral diluted with benzene leads to the formation of trichloroethyl ...
  30. [30]
    Conversion of hexachloroacetone into trichloroacetic and chloroform ...
    The conventional method for the preparation of tri- .chloroacetic acid is by oxidation of chloral with furning nitric lacid, permanganate or potassium chlorate.
  31. [31]
    US2370577A - Process for the production of trichloro acids
    As a further optional procedure, the trichloroaldehyde and the chlorate may be dissolved in water, and the acid may be added slowly during the reaction. When ...
  32. [32]
    Pesticides - Online Ethics Center
    Pure DDT is made by the reaction of chloral with chlorobenzene in the presence of sulfuric acid. A colorless, crystalline solid, it melts at 109 degrees ...
  33. [33]
    Chloral Hydrate - an overview | ScienceDirect Topics
    Chloral hydrate is thought to exert its effect through its metabolite trichloroethanol, which modulates GABAA receptors in a manner similar to the barbiturates.Missing: mechanism | Show results with:mechanism
  34. [34]
    Sedative-Hypnotic Drugs: Chloral Hydrate
    Nov 16, 2009 · Chloral hydrate, introduced into medicine by Liebreich 1 in 1869, has long been and still is one of the most effective and least expensive of the sedative- ...
  35. [35]
    Trichloroethanol potentiation of γ‐aminobutyric acid‐activated ...
    Since trichloroethanol is thought to be the active metabolite of chloral hydrate and other chloral derivative anaesthetics, potentiation of the GABA ...
  36. [36]
    Chloral Hydrate Dosage Guide + Max Dose, Adjustments - Drugs.com
    Sedative: 250 mg 3 times a day after meals; maximum dose of 2000 mg/day. Uses: Short-term treatment as a sedative or hypnotic. To reduce anxiety or produce ...Missing: formulations | Show results with:formulations
  37. [37]
    [PDF] Chloral Hydrate 500mg/5ml Oral Solution - ANSM
    Feb 22, 2023 · Chloral Hydrate 500mg/5ml Oral Solution should be administered as a single daily dose, between 15 to 30 minutes before bedtime with water or ...
  38. [38]
    [PDF] Chloral Hydrate 2021 - Australasian Neonatal Medicines Formulary
    ... chloral hydrate. Reimche et al administered 20-50 mg/kg/dose of chloral hydrate with repeat doses at 6-24 hour intervals and achieved adequate sedation and ...
  39. [39]
    (PDF) CHLORAL HYDRATE FOR CONTROL THE DOGS
    The result shows that Chlorhydrate can be used for dogs by mouth for calming and control dogs especially those vicious dogs.
  40. [40]
    Chloral Hydrate: Is It Still Being Used? Are There Safer Alternatives?
    Compounded Chloral Hydrate. Since 2010, ISMP has received no additional reports of errors involving pediatric sedation with chloral hydrate.
  41. [41]
    Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric ...
    Oct 6, 2021 · Prolonged use of chloral hydrate and cloral betaine has been associated with tolerance and the risks of dependence and abuse. The maximum ...
  42. [42]
    Chloral Hydrate - an overview | ScienceDirect Topics
    Chloral hydrate, 2,2,2-trichloro-1,1-ethandiol (4.3.1), is synthesized either by chlorination of ethanol or chlorination of acetaldehyde and the subsequent ...
  43. [43]
  44. [44]
    DDT Regulatory History: A Brief Survey (to 1975) | About EPA
    Sep 14, 2016 · After 1945, agricultural and commercial usage of DDT became widespread in the U.S. The early popularity of DDT, a member of the chlorinated ...
  45. [45]
    [PDF] Chloral hydrate is used as an intermediate in the production of ...
    Chloral hydrate is used as an intermediate in the production of insecticides, herbicides and hypnotic drugs. It has also been widely used as a sedative or ...Missing: current niche regions generics
  46. [46]
    Guide to Chemicals
    Alcohols are used as chemical intermediates and solvents in the textile, dye-stuff, chemical, detergent, perfume, food, beverage, cosmetics, and paint and ...
  47. [47]
    Historical Perspectives of Phenolic Resins - ACS Publications
    Nov 4, 2011 · In the early 1900's, Baekeland first disclosed the successful synthesis of polymers derived from the reaction of phenol and formaldehyde.Missing: chloral production like 20th
  48. [48]
  49. [49]
    Chloral Market Size, Share, Trend and Forcarst to 2025
    [110 Pages PDF] The Chloral Market Report shows that global Chloral market size was USD in 2025, and will expand at a CAGR of from 2025 to 2030.
  50. [50]
    CHLORAL HYDRATE - INCHEM
    The amount of chloral hydrate formed depends on the concentration of humic and fulvic substances and the conditions of chlorination. Additional chloral hydrate ...
  51. [51]
    [PDF] TOX-59: Chloral Hydrate (CASRN 302-17-0)
    This NTP report on the toxicity studies of chloral hydrate is based primarily on 16- and 17-day toxicity and metabolism studies that took place from June ...
  52. [52]
    Gastric mucosal injury induced by chloral hydrate - PubMed
    Gastric mucosal injury by chloral hydrate (CH) was investigated in the rat. Rats were injected with CH intraperitoneally or subcutaneously.Missing: irritant aldehyde reactivity corrosion
  53. [53]
    TRICHLOROACETIC ACID - NCBI - NIH
    Trichloroacetic acid is possibly carcinogenic to humans (Group 2B). Go to: References. Acharya S, Mehta K, Rodrigues S, et al. Administration of subtoxic ...
  54. [54]
    [PDF] Evidence on the Carcinogenicity of Trichloroacetic Acid and Its Salts
    Nov 1, 1999 · TCA caused liver tumors in male and female mice in multiple experiments by the predominant route of human exposure, i.e. drinking water. However ...
  55. [55]
    Trichloroethanol, an active metabolite of chloral hydrate, modulates ...
    Apr 29, 2023 · Our findings suggest that chloral hydrate, through its active metabolite TCE, inhibits TTX-R I Na and modulates various properties of these channels.
  56. [56]
    [PDF] workplace exposure limits - NJ.gov
    HANDLING AND STORAGE. * Prior to working with Chloral you should be trained on its proper handling and storage. * Chloral is not compatible with OXIDIZING ...
  57. [57]
    TRICHLOROACETALDEHYDE - CAMEO Chemicals - NOAA
    Chemical Formula: C2HCl3O. Flash Point: 167°F (NTP, 1992). Lower Explosive ... Molecular Weight: 147.39 (NTP, 1992). Water Solubility: Reaction (NTP, 1992).Missing: structure | Show results with:structure
  58. [58]
    Chloral SDS, 75-87-6 Safety Data Sheets - ECHEMI
    Avoid dust formation. Avoid breathing mist, gas or vapours.Avoid contacting with skin and eye. Use personal protective equipment.Wear chemical impermeable ...
  59. [59]
  60. [60]
    [PDF] sd15-environmentalsafety-final (pdf) - Euro Chlor
    The log Kow of the most stable variant, trichloroacetaldehyde, is 0.99 indicating it should not bioaccumulate [CICAD Chloral Hydrate]. Haloketones. Various ...